New York Assembly Bill A06509

New York 2025-2026 Regular Session

• Introduced: 3/5/25
• Refer: 3/5/25
• Report Pass: 4/28/25
• Refer: 4/28/25

Caption

Relates to ovarian cancer research; requires biennial reporting on recommendations from the health research and science board on the types of data that would be useful for ovarian cancer researchers.

Impact

The bill seeks to generate useful data that can aid researchers in their efforts to combat ovarian cancer. To achieve this, it compels state agencies to examine their current data collection practices and report on findings that may contribute to ongoing research. Such a systematic review would help in identifying gaps in research data and assist in the formulation of effective strategies to address ovarian cancer on a more scientific basis.

Summary

Bill A06509 aims to enhance ovarian cancer research by amending the public health law. The bill mandates that the governor appoint members to a health research and science board, focusing on improving the understanding and treatment of both breast and ovarian cancers. It emphasizes the importance of involving individuals who have survived these types of cancers and those associated with local cancer organizations in the decision-making processes concerning cancer research, thereby ensuring that the voices of those affected are heard in policy formulation.

Contention

One notable point of contention surrounding A06509 is the extent to which state agencies should be involved in cancer research data collection and reporting. Questions may arise over privacy issues related to health data and how this information would be utilized. Moreover, some stakeholders may express concerns over potential bureaucratic hurdles that could obstruct swift progress in cancer research. Overall, while the intention is to bolster cancer research, clarity on the implementation and oversight mechanisms will be essential to alleviate concerns from various stakeholders.